IC
JBIO

Ikarian Capital’s Jade Biosciences JBIO Stock Holding History

Ikarian Capital’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.2M Buy
512,349
+212,349
+71% +$3.07M 0.58% 47
2025
Q4 		$4.63M Buy
+300,000
New +$3.52M 0.36% 65
2024
Q4 		– Sell
-10,513
Closed -$769K – 177
2024
Q3 		$769K Hold
10,513
– – 0.11% 108
2024
Q2 		$611K Hold
10,513
– – 0.11% 89
2024
Q1 		$10.9M Buy
+10,513
New +$8.03M 1.19% 23
2023
Q2 		– Sell
-5,576
Closed -$3.94M – 134
2023
Q1 		$3.94M Buy
5,576
+1,921
+53% +$1.59M 0.89% 41
2022
Q4 		$3.75M Sell
3,655
-2,059
-36% -$1.49M 0.9% 34
2022
Q3 		$3.32M Buy
+5,714
New +$3.81M 0.66% 47

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return